Daniel Sabath News Today

A new blood test with the ability to quantify cancerous tumor cells in the bloodstream was developed this spring by researchers at UW Medicine and Seattle biotech company RareCyte, Inc.

Blood clots form naturally as a way to stop bleeding when someone is injured. But blood clots in patients with medical issues, such as mechanical heart valves or other heart conditions, can lead to a stroke or heart attack.